Mrs
Dr
Miss
Ms
Prof
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/2114215
Sanofi (SAN) - Financial and Strategic SWOT Analysis Review
Description:
Summary
Sanofi is a diversified healthcare company. It undertakes the discovery, development and marketing of therapeutic solutions. The company operates its business in three broad categories, namely, Pharmaceuticals, Vaccines and Animal Health. The Pharmaceutical segment of the company focuses on the development of products in the areas of cardiovascular diseases, thrombosis, diabetes, central nervous system (CNS), internal medicine and cancer. Sanofi offers Vaccines such as pediatric combinations and poliomyelitis vaccines, influenza, adult and adolescent booster, meningitis and travel, endemic and measles, mumps and rubella (MMR).
Sanofi Key Recent Developments
Mar 08, 2013: Zealand Pharma Provides Update On Pipeline Products
Feb 19, 2013: Sanofi India May Launch Sub-brands Of Its Flagship OTC Products
Feb 15, 2013: Andhra Pradesh High Court Issues Ruling In Favor Of Sanofi-Aventis In Double Tax Case
Feb 13, 2013: Sanofi To Invest €44m In Genzyme's Campus In Waterford, Ireland To Increase Lantus Production Capacities
Feb 07, 2013: Sanofi Reports Revenue Of €8.53 Billion In Q4 2012GDPH3811FSA
This comprehensive SWOT profile of Sanofi provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Sanofi is a diversified healthcare company. It undertakes the discovery, development and marketing of therapeutic solutions. The company operates its business in three broad categories, namely, Pharmaceuticals, Vaccines and Animal Health. The Pharmaceutical segment of the company focuses on the development of products in the areas of cardiovascular diseases, thrombosis, diabetes, central nervous system (CNS), internal medicine and cancer. Sanofi offers Vaccines such as pediatric combinations and poliomyelitis vaccines, influenza, adult and adolescent booster, meningitis and travel, endemic and measles, mumps and rubella (MMR).
Sanofi Key Recent Developments
Mar 08, 2013: Zealand Pharma Provides Update On Pipeline Products
Feb 19, 2013: Sanofi India May Launch Sub-brands Of Its Flagship OTC Products
Feb 15, 2013: Andhra Pradesh High Court Issues Ruling In Favor Of Sanofi-Aventis In Double Tax Case
Feb 13, 2013: Sanofi To Invest €44m In Genzyme's Campus In Waterford, Ireland To Increase Lantus Production Capacities
Feb 07, 2013: Sanofi Reports Revenue Of €8.53 Billion In Q4 2012GDPH3811FSA
This comprehensive SWOT profile of Sanofi provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Contents:
List of Tables
List of Figures
Section 1 - About the Company
Sanofi - Key Facts
Sanofi - Key Employees
Sanofi - Key Employee Biographies
Sanofi - Major Products and Services
Sanofi - Pharmaceutical Pipeline Products Data
Sanofi, Pipeline Products by Therapy Area
Sanofi, Pipeline Products by Development Phase
Sanofi - Medical Equipment Pipeline Products Data
Sanofi Pipeline Products by Equipment Type
Sanofi Pipeline Products by Development Stage
Sanofi - History
Sanofi - Company Statement
Sanofi - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Sanofi - Key Manufacturing Facilities
Affiliate
Joint Venture
Section 2 – Company Analysis
Sanofi - Business Description
Sanofi - Corporate Strategy
Sanofi - SWOT Analysis
SWOT Analysis - Overview
Sanofi - Strengths
Strength - Broad Product Portfolio
Strength - Strong Research and Development Activities
Strength - Geographical Diversification
Sanofi - Weaknesses
Weakness - Reliance on Third Parties
Weakness - Product Recalls
Weakness - Discontinuation of Late Phase Projects
Weakness - Payouts to Settle Allegations
Sanofi - Opportunities
Opportunity - Inorganic Growth Drivers: Acquisitions
Opportunity - Strategic Agreements
Opportunity - Product Approvals and Launches
Opportunity - Strong Product Pipeline
Sanofi - Threats
Threat - Competitive Landscape
Threat - Stringent Government Regulations
Threat - Uncertain R&D Outcomes
Threat - Growing Parallel Trade
Sanofi - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Sanofi, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Sanofi, Medical Equipment, Deals By Year, 2007 to YTD 2013
Sanofi, Medical Equipment, Deals By Type, 2007 to YTD 2013
Sanofi, Recent Deals Summary
Section 5 – Company’s Recent Developments
Sanofi, Recent Developments
Mar 08, 2013: Zealand Pharma Provides Update On Pipeline Products
Feb 19, 2013: Sanofi India May Launch Sub-brands Of Its Flagship OTC Products
Feb 15, 2013: Andhra Pradesh High Court Issues Ruling In Favor Of Sanofi-Aventis In Double Tax Case
Feb 13, 2013: Sanofi To Invest €44m In Genzyme's Campus In Waterford, Ireland To Increase Lantus Production Capacities
Feb 07, 2013: Sanofi Reports Revenue Of €8.53 Billion In Q4 2012
Jan 27, 2013: Sanofi Launches Enterogermina For Treatment Of Gastrointestinal Disorders
Jan 16, 2013: DKSH Expands Partnership With Sanofi In Malaysia
Jan 08, 2013: Sanofi Provides Update On Its R&D Pipeline At JP Morgan Healthcare Conference
Jan 08, 2013: OctoPlus Signs Master Service Agreement With Sanofi
Dec 16, 2012: Sanofi Breaks Ground For New Facility In King Abdullah Economic City, Saudi Arabia
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer
List of Tables
Sanofi, Key Facts
Sanofi, Key Employees
Sanofi, Key Employees (cont..)
Sanofi, Key Employee Biographies
Sanofi, Major Products and Services
Sanofi, Number of Pipeline Products by Therapy Area
Sanofi, Number of Pipeline Products by Development Stage
Sanofi, Pipeline Products By Therapy Area and Development Phase
Sanofi Number of Pipeline Products by Equipment Type
Sanofi Pipeline Products by Equipment Type
Sanofi Number of Pipeline Products by Development Stage
Sanofi Pipeline Products by Development Stage
Sanofi, History
Sanofi, Other Locations
Sanofi, Subsidiaries
Sanofi, Key Manufacturing Facilities
Sanofi, Affiliate
Sanofi, Joint Venture
Sanofi, Key Competitors
Sanofi, Ratios based on current share price
Sanofi, Annual Ratios
Sanofi, Interim Ratios
Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Sanofi, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Sanofi, Medical Equipment, Deals By Year, 2007 to YTD 2013
Sanofi, Medical Equipment, Deals By Type, 2007 to YTD 2013
Sanofi, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Sanofi, Pipeline Products by Therapy Area
Sanofi, Pipeline Products by Development Phase
Sanofi Pipeline Products by Equipment Type
Sanofi Pipeline Products by Development Stage
Sanofi, Performance Chart (2008 - 2012)
Sanofi, Ratio Charts
Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Sanofi, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013
Sanofi, Medical Equipment, Deals By Year, 2007 to YTD 2013
Sanofi, Medical Equipment, Deals by Type, 2007 to YTD 2013
List of Figures
Section 1 - About the Company
Sanofi - Key Facts
Sanofi - Key Employees
Sanofi - Key Employee Biographies
Sanofi - Major Products and Services
Sanofi - Pharmaceutical Pipeline Products Data
Sanofi, Pipeline Products by Therapy Area
Sanofi, Pipeline Products by Development Phase
Sanofi - Medical Equipment Pipeline Products Data
Sanofi Pipeline Products by Equipment Type
Sanofi Pipeline Products by Development Stage
Sanofi - History
Sanofi - Company Statement
Sanofi - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Sanofi - Key Manufacturing Facilities
Affiliate
Joint Venture
Section 2 – Company Analysis
Sanofi - Business Description
Sanofi - Corporate Strategy
Sanofi - SWOT Analysis
SWOT Analysis - Overview
Sanofi - Strengths
Strength - Broad Product Portfolio
Strength - Strong Research and Development Activities
Strength - Geographical Diversification
Sanofi - Weaknesses
Weakness - Reliance on Third Parties
Weakness - Product Recalls
Weakness - Discontinuation of Late Phase Projects
Weakness - Payouts to Settle Allegations
Sanofi - Opportunities
Opportunity - Inorganic Growth Drivers: Acquisitions
Opportunity - Strategic Agreements
Opportunity - Product Approvals and Launches
Opportunity - Strong Product Pipeline
Sanofi - Threats
Threat - Competitive Landscape
Threat - Stringent Government Regulations
Threat - Uncertain R&D Outcomes
Threat - Growing Parallel Trade
Sanofi - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Sanofi, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Sanofi, Medical Equipment, Deals By Year, 2007 to YTD 2013
Sanofi, Medical Equipment, Deals By Type, 2007 to YTD 2013
Sanofi, Recent Deals Summary
Section 5 – Company’s Recent Developments
Sanofi, Recent Developments
Mar 08, 2013: Zealand Pharma Provides Update On Pipeline Products
Feb 19, 2013: Sanofi India May Launch Sub-brands Of Its Flagship OTC Products
Feb 15, 2013: Andhra Pradesh High Court Issues Ruling In Favor Of Sanofi-Aventis In Double Tax Case
Feb 13, 2013: Sanofi To Invest €44m In Genzyme's Campus In Waterford, Ireland To Increase Lantus Production Capacities
Feb 07, 2013: Sanofi Reports Revenue Of €8.53 Billion In Q4 2012
Jan 27, 2013: Sanofi Launches Enterogermina For Treatment Of Gastrointestinal Disorders
Jan 16, 2013: DKSH Expands Partnership With Sanofi In Malaysia
Jan 08, 2013: Sanofi Provides Update On Its R&D Pipeline At JP Morgan Healthcare Conference
Jan 08, 2013: OctoPlus Signs Master Service Agreement With Sanofi
Dec 16, 2012: Sanofi Breaks Ground For New Facility In King Abdullah Economic City, Saudi Arabia
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer
List of Tables
Sanofi, Key Facts
Sanofi, Key Employees
Sanofi, Key Employees (cont..)
Sanofi, Key Employee Biographies
Sanofi, Major Products and Services
Sanofi, Number of Pipeline Products by Therapy Area
Sanofi, Number of Pipeline Products by Development Stage
Sanofi, Pipeline Products By Therapy Area and Development Phase
Sanofi Number of Pipeline Products by Equipment Type
Sanofi Pipeline Products by Equipment Type
Sanofi Number of Pipeline Products by Development Stage
Sanofi Pipeline Products by Development Stage
Sanofi, History
Sanofi, Other Locations
Sanofi, Subsidiaries
Sanofi, Key Manufacturing Facilities
Sanofi, Affiliate
Sanofi, Joint Venture
Sanofi, Key Competitors
Sanofi, Ratios based on current share price
Sanofi, Annual Ratios
Sanofi, Interim Ratios
Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Sanofi, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Sanofi, Medical Equipment, Deals By Year, 2007 to YTD 2013
Sanofi, Medical Equipment, Deals By Type, 2007 to YTD 2013
Sanofi, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Sanofi, Pipeline Products by Therapy Area
Sanofi, Pipeline Products by Development Phase
Sanofi Pipeline Products by Equipment Type
Sanofi Pipeline Products by Development Stage
Sanofi, Performance Chart (2008 - 2012)
Sanofi, Ratio Charts
Sanofi, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Sanofi, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013
Sanofi, Medical Equipment, Deals By Year, 2007 to YTD 2013
Sanofi, Medical Equipment, Deals by Type, 2007 to YTD 2013
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/2114215
Order by Fax - using the order form below
Order By Post - print the order form below and send to
Order by Fax - using the order form below
Order By Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Printed Wednesday, June 19, 2013
1:54:32 AM
1:54:32 AM
Fax order form
To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
Product name
Sanofi (SAN) - Financial and Strategic SWOT Analysis Review
Web Address
http://www.researchandmarkets.com/reports/2114215
Office Code
OC8DIQQMSTVWVT
Report Formats
Please enter the quantity of the report format you require.
| Format | Quantity | Price |
|---|---|---|
| Electronic (PDF) - Single User |
|
EUR 96 |
| Electronic (PDF) - Site License |
|
EUR 191 |
| Electronic (PDF) - Enterprisewide |
|
EUR 287 |
Contact information
Please enter all the information below in block capitals.
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
Mrs
Dr
Miss
Ms
Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Page 2 of 2
Printed Wednesday, June 19, 2013
1:54:32 AM
1:54:32 AM
Payment information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
Pay by Check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Pay by Wire Transfer:
Please transfer funds to:
Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp